OK. I have rna-seq data from 3 mice. I want to align this data to the mouse reference -- either genome, which seems like overkill, or to all the known mRNAs from Acembly -- which I have in FASTA format.
The data came from 454 as FASTA (.fna) and .qual files.
I've also obtained the SFF files.
TopHat didn't seem to like the FASTQ files I generated from the FASTA and .qual files using BioPython's SeqIO functions.
There's a really big range of read lengths in this data, which also seems to make a lot of the tools (since they were engineered for Illumina GA output) unhappy.
Thoughts? Advice? I'm on a Mac Pro, but have 64-bit linux and Windows XP running via virtualization.
Thanks,
Anand
-
I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.
Here are nine questions we think about, in roughly the order they matter, before...06-18-2026, 07:11 AM -
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM